Professional Summary

Professional Overview

Rock Liu is a seasoned biopharmaceutical executive with over 20 years of industry experience. As the Senior Vice President at TandemAI, he leverages his extensive expertise in biology, pharmacology, and drug discovery to drive innovation and accelerate the development of transformative therapies.

Experience Summary

Current Role

In his current role as Senior Vice President at TandemAI, Rock is responsible for overseeing the company's biology and pharmacology functions. He leads a team of talented scientists in advancing the company's pipeline of promising drug candidates, utilizing cutting-edge AI and computational technologies to streamline the drug discovery process. Under his leadership, TandemAI has achieved significant milestones, including the successful advancement of multiple drug candidates into clinical trials.

Career Progression

Prior to joining TandemAI, Rock served as the Vice President of Biology and Pharmacology at Novostar Pharmaceuticals, where he spearheaded the development of several novel therapeutics targeting unmet medical needs. Before that, he held the role of Vice President and Head of Biology and DMPK at Sundia MediTech Co., Ltd., where he played a pivotal role in the company's growth and the advancement of its drug pipeline. Earlier in his career, Rock served as a Senior Director of Biology at ChemPartner and a Senior Group Leader at Eurofins, where he honed his expertise in various aspects of drug discovery and development.

Academic Background

Rock Liu holds a Ph.D. in Pharmacology from the University of California, San Diego, with a focus on oncology and immunology. His academic achievements include numerous publications in peer-reviewed journals and presentations at international scientific conferences.

Areas of Expertise

• Drug discovery and development

• Pharmacology and translational research

• Computational biology and AI-driven drug design

• Biomarker identification and validation

• Cross-functional team leadership and collaboration

Professional Impact

Throughout his career, Rock has made significant contributions to the biopharmaceutical industry. He has led the successful progression of multiple drug candidates from early discovery to advanced clinical stages, with several compounds currently in late-stage trials or pending regulatory approval. Rock's expertise in leveraging cutting-edge technologies has helped his teams improve the efficiency and success rate of drug development programs, ultimately benefiting patients in need.

Conclusion

With his extensive experience, technical expertise, and proven track record of success, Rock Liu is a valuable asset to the biopharmaceutical industry. As the Senior Vice President at TandemAI, he is poised to continue driving innovation and delivering transformative therapies that improve patient outcomes.